High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature
Leptomeningeal metastasis (LM) in breast cancer is associated with significant morbidity and mortality. While there is currently no standard therapy, treatment options include craniospinal radiotherapy, intrathecal chemotherapy and systemic chemotherapy. Craniospinal radiotherapy has not demonstrate...
Main Authors: | Jonathan T. Kapke, Robert J. Schneidewend, Zeeshan A. Jawa, Chiang-Ching Huang, Jennifer M. Connelly, Christopher R. Chitambar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Hematology/Oncology and Stem Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387619300792 |
Similar Items
-
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
by: F. Bazan, et al.
Published: (2019-11-01) -
The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients
by: Traivaree C, et al.
Published: (2018-10-01) -
The increasing doses of methotrexate pharmacokinetics after intravenous administration in rats - model selection
by: Rajšić Ivana, et al.
Published: (2021-01-01) -
Intravenous Infusion of High Dose Methotrexate, Metabolism of Pteridines and Consequences for the Tetrahydrobiopterin Dependent Hydroxylases
by: Dhondt J.-L., et al.
Published: (1991-02-01) -
Dural and Leptomeningeal Spine Metastases of Breast Cancer
by: Fernando Matos, et al.
Published: (2019-01-01)